Robert Gemmill to Cell Proliferation
This is a "connection" page, showing publications Robert Gemmill has written about Cell Proliferation.
Connection Strength
0.177
-
Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. J Thorac Oncol. 2009 Dec; 4(12):1455-65.
Score: 0.061
-
Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5. Oncogene. 2005 May 12; 24(21):3503-11.
Score: 0.044
-
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 08; 162(2):463-473.
Score: 0.031
-
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS One. 2016; 11(1):e0147344.
Score: 0.023
-
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination. Invest New Drugs. 2012 Dec; 30(6):2303-17.
Score: 0.017